Skip to main content
OpenTrials
Completed

NCT Number: NCT07344688

The Effect of White Tea in Healthy Human Subjects

This clinical study aims to determine the effects of consuming white tea infusion (Camellia sinensis) on healthy subjects over a period of 14 days. The main questions it aims to answer are:

1. Determine the effect of white tea consumption on the anthropometry of healthy subjects. 2. Determine the effect of white tea consumption on the biochemical parameters of healthy subjects. 3. Determine the effect of white tea consumption on hematology parameters that are related to anemia case in healthy subjects. 4. Determine the effect of white tea consumption on the activity of first-line antioxidant enzymes in healthy subjects

Researchers used only one treatment group, and respondents knew which treatment they would receive (single-arm and open-labelled), namely white tea infusion to maintain human body health. Participants will:

1. Follow the washout stage for 7 days 2. Drink white tea infusion every day for 14 days. 3. Follow up to monitor adverse effects after consuming white tea; this stage will be conducted for 7 days. 4. Report all food and beverages consumed by respondents during the study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Pharmacy, Padjadjaran University

Sumedang, West Java, 45363, Indonesia

About this study

Unhealthy lifestyles, including alcohol consumption, illegal drug use, radiation exposure, and the preparation of food (e.g. smoked meat, used oil, and fat) and polluted environments (water and air pollution) are triggering an increase in cases of degenerative diseases worldwide, including ischaemic heart disease, diabetes, cancer, atherosclerosis, liver disease, kidney disease, chronic obstructive pulmonary disease, and others. The body's natural defences can decline at any time due to the development of reactive oxygen species (ROS) caused by unhealthy lifestyle factors and environmental pollution. Exogenous antioxidants are important for maintaining the body's defence system against excessive ROS. This study will examine the potential of compounds in white tea infusion in maintaining human health by monitoring several parameters, including anthropometric, biochemical, haematological, and antioxidant enzyme activity. The anthropometric parameters tested include body weight, height, waist circumference, systolic blood pressure, and diastolic blood pressure. Biochemical parameters include lipid profile (total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides), alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum creatinine levels, estimated glomerular filtration rate (eGFR), and urea nitrogen levels. The haematological parameters used are directly related to the indication of anaemia, including red blood cell count, haemoglobin, haematocrit, mean corpuscular haemoglobin (MCH), and mean corpuscular volume (MCV). Finally, there are the first-line antioxidant enzyme activity parameters, including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). This examination was conducted before and after the 14-day white tea infusion treatment to observe the effects of the treatment. Male and female healthy volunteers were instructed to follow three stages of research, including:

  • Washout phase : respondents are advised to avoid products with high polyphenol content such as turmeric, ginger, galangal, grapes, apples, oranges, coffee, other types of tea, and chocolate, either directly or in processed products.
  • Treatment phase: respondents continue to avoid the products avoided during the washout process. In this phase, respondents will consume white tea infusion (4 grams of WT in 200 mL of freshly boiled water) every day for 14 days.
  • Observational phase: the phase is conducted for 7 days to monitor the presence or absence of side effects after 14 days of consuming white tea infusion.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The participants are the community around Padjadjaran University with an age range of 20 - 35 years old. Female respondents were unmarried.
  • The participants are non-smoker.
  • The participants should have no history of anemia, chronic disease, hepatic and renal dysfunction.
  • The participants are willing to follow the research process until its finish by signing an informed consent form.

Exclusion criteria

  • The participants who are undergoing drug therapy and taking vitamin supplements.
  • The participants who failed due to illness or are unable to continue the examination to the end.
  • Respondents with pre-treatment biochemical results not within the normal range

Treatment and study plan

White tea intervention

Other
  • White tea infusion was prepared by brewing 4 grams of white tea in 200 mL of hot water.
  • Healthy respondents were asked to consume the white tea infusion for 14 days.
  • The focus of this study was to observe the effect of white tea infusion on antioxidant enzyme activity and its relationship with anthropometric, biochemical, and haematological parameters.

Primary outcomes

  1. Antioxidant Enzymes Analysis

    Time frame: 14 days

    Comparing the antioxidant activity values of enzymes including superoxide dismutase, catalase, and glutathione peroxidase in pre and post white tea treatment (day 0 and day 15). The increased activity of antioxidant enzymes signifies an enhancement in the body's capability to combat free radicals. The analysis will be conducted using a reagent kit to obtain the antioxidant enzyme activity values in the respondents' serum. All antioxidant enzyme parameter values are expressed in U/mL.

  2. Liver Function Analysis

    Time frame: 14 days

    The effect of the product on liver function will be analysed based on SGOT and SGPT values. A drastic increase compared to the pre-intervention level indicates potential toxicity. Both parameters will be expressed in units of ukat/L.

  3. estimated Glomerular filtration rate

    Time frame: 14 days

    A drastic decrease in eGFR indicates the potential toxicity of white tea beverages. eGFR results of respondents will be expressed in mL/min/1.73m2

  4. Lipid profile measurement

    Time frame: 14 days

    The effect of product administration on lipid profile was assessed by measuring total cholesterol, triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) parameters. Product effectiveness was determined based on the stability or decrease in total cholesterol, triglycerides, and LDL values, as well as an increase in HDL values post-treatment compared to pre-treatment values. Total cholesterol, triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) will be expressed in mmol/L

  5. Fasting blood glucose measurement

    Time frame: 14 days

    Fasting blood glucose will be expressed in mmol/L

  6. Serum creatinine Analysis

    Time frame: 14 days

    An elevated serum creatinine level is an indication of potential toxicity associated with white tea consumption. Serum creatinine level will be expressed in umol/L

  7. Blood Urea Nitrogen Analysis

    Time frame: 14 days

    An elevated blood urea nitrogen level is an indication of potential toxicity associated with white tea consumption. The parameter will be written in units of mmol/L

Secondary outcomes

  1. Body Weight Measurement

    Time frame: 14 days

    The body weight of respondents will be measured on day 0 and day 15 after administration of white tea treatment. Body weight values before and after treatment will be analysed. Body weight values will be recorded in kilograms (kg)

  2. Body Height Measurement

    Time frame: 14 days

    Height measurements will be taken on days 0 and 15. Measurements will be taken to calculate BMI values for further analysis. Height values will be recorded in centimetres (cm).

  3. Body Mass Index

    Time frame: 14 days

    Body mass index measurements will be taken using weight and height data. The BMI result is recorded in kg/m^2, then the analysis will be classified into the categories of underweight (BMI range <18.5 kg/m^2) healthy (BMI range 18.5 - 24.9 kg/m^2), overweight (BMI range 25.0 - 29.9 kg/m^2) and obese (BMI range > 29.9 kg/m^2).

  4. Waist Circumference Measurement

    Time frame: 14 days

    Waist circumference measurements were taken on days 0 and 15 using a measuring tape and expressed in centimetres (cm). The results before and after treatment will be analysed.

  5. Blood Pressure Measurement

    Time frame: 14 days

    Both systolic blood pressure or diastolic blood pressure will be measured.

  6. Number of participants with serious adverse events related to study product

    Time frame: 14 days

    Signs and symptoms of adverse event related to study product including nausea, vomiting, dizziness, burning sensation in the stomach, excessive fatigue, constipation, and excessive urination will be assessed daily for 14 days since the first administration of white tea beverages.

  7. Red Blood Cells Measurement

    Time frame: 14 days

    Red blood cell (RBC) parameters are one of the parameters used to assess whether white tea beverages have the potential to cause anaemia. Tests were conducted on days 0 and 15, the difference in RBC values was analysed, and RBC values were expressed in 10^6/uL.

  8. Haemoglobin Measurement

    Time frame: 14 days

    Haemoglobin parameters are one of the parameters used to assess whether white tea beverages have the potential to cause anaemia. Tests were conducted on days 0 and 15, the difference in haemoglobin values was analysed, and haemoglobin values were expressed in grams/decilitre (g/dL)

  9. Haematocrit Measurement

    Time frame: 14 days

    Haematocrit parameters are one of the parameters used to assess whether white tea beverages have the potential to cause anaemia. Tests were conducted on days 0 and 15, the difference in haematocrit values was analysed, and haematocrit values were expressed in percentage (%).

  10. Mean Corpuscular Haemoglobin Measurement

    Time frame: 14 days

    Mean Corpuscular haemoglobin (MCH) parameters are one of the parameters used to assess whether white tea beverages have the potential to cause anaemia. Tests were conducted on days 0 and 15, the difference in MCH values was analysed, and MCH values were expressed in picograms (pg).

  11. Mean Corpuscular Volume Measurement

    Time frame: 14 days

    Mean Corpuscular Volume (MCV) parameters are one of the parameters used to assess whether white tea beverages have the potential to cause anaemia. Tests were conducted on days 0 and 15, the difference in MCV values was analysed, and MCV values were expressed in femtoliters (fL).

  12. Daily intake

    Time frame: 28 days

    The daily report of respondents incorporates information regarding their daily activities and the consumption of food and beverages during the 28-day research period. Respondents will be asked to submit this data every day via personal chat (WhatsApp).

Sponsors and collaborators

Lead sponsor

Universitas Padjadjaran

Other

Registry information

Official study title

Effect of White Tea (Camellia Sinensis L.) Beverages on Anthropometric, Hematological, Biochemical and First Line Antioxidant Enzymes Activity of Healthy Human (Superoxide Dismutase, and Glutathione Peroxidase)

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jan 15, 2026
Registry last updated
Apr 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.